49
Grants received
$5.8M
Total received
$119K
Average grant
12
Unique funders
Grants received by year
2024
$2.0M
6 grants
2023
$1.9M
8 grants
2022
$244K
10 grants
2021
$864K
10 grants
2020
$479K
5 grants
2019
$402K
4 grants
2018
$500
1 grants
2017
$750
1 grants
2016
$500
1 grants
2014
$1K
1 grants
2013
$11K
2 grants
Top funders
7 grants · last 2024
$2.3M
4 grants · last 2024
$1.4M
2 grants · last 2024
$986K
15 grants · last 2023
$551K
1 grant · last 2024
$250K
1 grant · last 2019
$200K
2 grants · last 2024
$100K
1 grant · last 2013
$11K
10 grants · last 2024
$9K
4 grants · last 2023
$2K
Recent grants received · most recent first
Grants are matched to this organization by EIN. ✓ Exact = matched by exact name + state; ≈ Likely = inferred from a closely similar name.
$750K
NUCLEIC ACIDS SEQUENCING, MICROSCOPY, AND IMAGING EQUIPMENT
TY 2024 · ✓ Exact
$525K
MECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS
TY 2024 · ✓ Exact
$379K
INTEGRIN AUTOANTIBODIES IN THE PATHOGENESIS OF ULCERATIVE COLITIS
TY 2024 · ✓ Exact
$250K
$50K
$2K
LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D
TY 2023 · ✓ Exact
$810K
$500K
$298K
LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D
TY 2023 · ✓ Exact
$132K
$100K
$50K
$1K
$557
$100K
$29K
$24K
$23K
$22K
$22K
$18K
$6K
$1K
$712
LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN IN T1D
TY 2021 · ✓ Exact
$581K
GUIDELINES FOR CLINICAL FOLLOW-UP OF MULTIPLE ISLET AUTOANTIBODIES
TY 2021 · ✓ Exact
$70K
GUIDELINES FOR CLINICAL PRACTICE OF AUTOANTIBODY POSITIVE INDIVIDUALS
TY 2021 · ✓ Exact
$70K
$50K
$27K
$22K
$21K
$21K
$1K
$603
NUCLEIC ACID SEQUENCING AND CELL SORTING EQUIPMENT PURCHASE
TY 2020 · ✓ Exact
$461K
$17K
$750
$512
$237
$200K
$150K
$51K
$500
$500
$750
$500
$1K
$11K
$250
Source: IRS Form 990-PF, Part XV. Up to 50 most recent grants shown.